• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Rises 1.5%; Nasdaq Jumps Over 100 Points

    10/24/22 3:44:06 PM ET
    $AGTC
    $AXDX
    $IMRA
    $MOTS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $AGTC alert in real time by email

    U.S. stocks traded higher toward the end of trading, with the Dow Jones surging more than 450 points on Monday.

    The Dow traded up 1.50% to 31,547.65 while the NASDAQ rose 1.04% to 10,972.47. The S&P 500 also rose, gaining, 1.38% to 3,804.48.

    Also check this: Market Volatility Decreases As Dow Jumps More Than 700 Points


    Leading and Lagging Sectors


    Health care shares climbed 2.1% on Monday. Leading the sector was strength from Vaxcyte, Inc. (NASDAQ:PCVX) and IMARA Inc. (NASDAQ:IMRA).


    In trading on Monday, materials shares fell by 0.3%.


    Top Headline

     

    The S&P Global manufacturing PMI dropped to 49.9 in October from 52 in September, down from market estimates of 51. US services PMI fell to 46.6 in October from 49.3 in the prior month.

     

    Equities Trading UP

     

    • Vaxcyte, Inc. (NASDAQ:PCVX) shares shot up 67% to $34.29 after the company announced positive topline results from the Phase 1/2 clinical proof-of-concept study evaluating the safety, tolerability and immunogenicity of VAX-24.
    • Shares of Applied Genetic Technologies Corporation (NASDAQ:AGTC) got a boost, shooting 60% to $0.3845 after Syncona announced it will acquire the company for $0.34 per share in cash plus up to $0.73 per CVR.
    • Motus GI Holdings, Inc. (NASDAQ:MOTS) shares were also up, gaining 30% to $2.0785 after the company announced clinical data for Pure-Vu EVS in three poster presentations at the American College of Gastroenterology 2022 Annual Scientific Meeting.

     

    Equities Trading DOWN

    • Tricida, Inc. (NASDAQ:TCDA) shares tumbled 94% to $0.5994 after the company announced its VALOR-CKD trial did not meet its primary endpoint.
    • Shares of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) were down 40% to $0.9550 after the FDA clarified to the company that it must obtain a 510(k) clearance in order to continue marketing and distributing the Accelerate Arc Products in the United States.
    • Soluna Holdings, Inc. (NASDAQ:SLNH) was down, falling 34% to $1.1950 after the company reported pricing of $2 million underwritten public offering of common stock.


    Also check out: Moderna, Amazon, Tesla, And Other Big Gainers From Friday


    Commodities

    In commodity news, oil traded down 0.3% to $84.79, while gold traded down 0.1% at $1,654.70.


    Silver traded down 0.7% to $19.225 on Monday while copper fell 1.2% to $3.4340.


    Euro zone


    European shares were higher today. The eurozone’s STOXX 600 gained 1.4%, London’s FTSE 100 rose 0.64% while Spain’s IBEX 35 Index rose 1.79%. The German DAX gained 1.58%, French CAC 40 gained 1.59% and Italy’s FTSE MIB Index gained 1.93%.

    UK’s manufacturing PMI declined to 45.8 in October from 48.4 a month ago. The S&P Global Eurozone manufacturing PMI dropped to 46.6 in October from 48.4 in September, while services PMI fell to 48.2 from 48.8. The S&P Global Composite PMI in Germany fell to 44.1 in October from 45.7 in the previous month, while French Composite PMI dropped to 50 in October from 51.2 in September.

     

    Economics

     

    • The Chicago Fed National Activity Index came in unchanged at +0.10 in September, compared to the prior month's revised reading.
    • The S&P Global manufacturing PMI dropped to 49.9 in October from 52 in September, down from market estimates of 51. US services PMI fell to 46.6 in October from 49.3 in the prior month.


    Check out this: Investor Sentiment Improves Ahead Of Earnings Results


    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 99,087,540 cases with around 1,092,940 deaths. India confirmed a total of at least 44,644,070 cases and 528,970 deaths, while France reported over 36,599,820 COVID-19 cases with 156,330 deaths. In total, there were at least 632,978,010 cases of COVID-19 worldwide with more than 6,583,160 deaths.

    Get the next $AGTC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGTC
    $AXDX
    $IMRA
    $MOTS

    CompanyDatePrice TargetRatingAnalyst
    Vaxcyte Inc.
    $PCVX
    1/7/2026$90.00 → $110.00Buy
    Needham
    Soluna Holdings Inc.
    $SLNH
    12/11/2025$5.00Neutral → Buy
    H.C. Wainwright
    Vaxcyte Inc.
    $PCVX
    9/12/2025$38.00Neutral
    Goldman
    Soluna Holdings Inc.
    $SLNH
    7/23/2025Neutral
    H.C. Wainwright
    Vaxcyte Inc.
    $PCVX
    4/22/2025Overweight
    Cantor Fitzgerald
    Vaxcyte Inc.
    $PCVX
    12/20/2024$135.00Buy
    Goldman
    Vaxcyte Inc.
    $PCVX
    12/7/2023$69.00Buy
    Mizuho
    Vaxcyte Inc.
    $PCVX
    4/18/2023Outperform
    TD Cowen
    More analyst ratings

    $AGTC
    $AXDX
    $IMRA
    $MOTS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Vaxcyte to Present at the Guggenheim Emerging Outlook: Biotech Summit

    SAN CARLOS, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (NASDAQ:PCVX), a clinical-stage vaccine innovation company, today announced that Company management will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit in New York on Thursday, February 12, 2026 at 1:30 p.m. ET / 10:30 a.m. PT. A live webcast of the fireside chat can be accessed through the Investors & Media section of the Company's website at http://investors.vaxcyte.com. A replay of the webcast will be available for approximately 30 days following the conference. About Vaxcyte Vaxcyte is a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the cons

    2/5/26 4:05:00 PM ET
    $PCVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Soluna Executes Equipment Supply Agreement with Cormint for 12 MW Kati 1 Deployment

    Agreement is a blueprint for future deployments across pipeline Soluna Holdings, Inc. ("Soluna" or the "Company") (NASDAQ:SLNH), a developer of green data centers for intensive computing applications, including Bitcoin mining and AI, today announced that it has executed an Equipment Supply Agreement with Cormint Data Systems ("Cormint"), a Texas based firm that has designed, delivered, and operationalized more than 130MW of data center infrastructure, to support a 12 MW deployment at Project Kati 1 in Willacy County, Texas. Under the agreement, Cormint will design, procure, and deliver eight modular data center units for Soluna's 12 MW Kati 1 deployment. The modular units are fully inte

    2/3/26 7:30:00 AM ET
    $SLNH
    EDP Services
    Technology

    Vaxcyte Announces Closing of $632.5 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

    SAN CARLOS, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (NASDAQ:PCVX), a clinical-stage vaccine innovation company, announced today the closing of its previously announced underwritten public offering of 12,650,000 shares of common stock at a public offering price of $50.00 per share. This includes the exercise in full by the underwriters of their option to purchase up to 1,650,000 additional shares of common stock at the public offering price per share, less underwriting discounts and commissions. The aggregate gross proceeds to Vaxcyte from this offering were $632.5 million, before deducting underwriting discounts and commissions and other offering expenses payable by Vaxcyte

    2/2/26 4:05:00 PM ET
    $PCVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGTC
    $AXDX
    $IMRA
    $MOTS
    SEC Filings

    View All

    Soluna Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Soluna Holdings, Inc (0000064463) (Filer)

    2/3/26 7:30:42 AM ET
    $SLNH
    EDP Services
    Technology

    SEC Form 8-K filed by Vaxcyte Inc.

    8-K - Vaxcyte, Inc. (0001649094) (Filer)

    2/2/26 4:01:31 PM ET
    $PCVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B5 filed by Vaxcyte Inc.

    424B5 - Vaxcyte, Inc. (0001649094) (Filer)

    1/30/26 5:12:46 PM ET
    $PCVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGTC
    $AXDX
    $IMRA
    $MOTS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham reiterated coverage on Vaxcyte with a new price target

    Needham reiterated coverage of Vaxcyte with a rating of Buy and set a new price target of $110.00 from $90.00 previously

    1/7/26 8:03:12 AM ET
    $PCVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Soluna Holdings upgraded by H.C. Wainwright with a new price target

    H.C. Wainwright upgraded Soluna Holdings from Neutral to Buy and set a new price target of $5.00

    12/11/25 8:46:07 AM ET
    $SLNH
    EDP Services
    Technology

    Goldman initiated coverage on Vaxcyte with a new price target

    Goldman initiated coverage of Vaxcyte with a rating of Neutral and set a new price target of $38.00

    9/12/25 7:53:21 AM ET
    $PCVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGTC
    $AXDX
    $IMRA
    $MOTS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF EXECUTIVE OFFICER Pickering Grant gifted 100,000 shares, decreasing direct ownership by 20% to 400,908 units (SEC Form 4)

    4 - Vaxcyte, Inc. (0001649094) (Issuer)

    1/16/26 5:10:28 PM ET
    $PCVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    PRESIDENT AND CFO Guggenhime Andrew gifted 61,850 shares and received a gift of 61,850 shares, decreasing direct ownership by 50% to 62,459 units (SEC Form 4)

    4 - Vaxcyte, Inc. (0001649094) (Issuer)

    1/16/26 5:09:55 PM ET
    $PCVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Brandicourt Olivier was granted 1,357 shares, increasing direct ownership by 118% to 2,505 units (SEC Form 4)

    4 - Vaxcyte, Inc. (0001649094) (Issuer)

    1/16/26 5:08:29 PM ET
    $PCVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGTC
    $AXDX
    $IMRA
    $MOTS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Tunison John bought $5,280 worth of 9.0% Series A Cumulative Perpetual Preferred Stock (2,000 units at $2.64), increasing direct ownership by 8% to 27,000 units (SEC Form 4)

    4 - Soluna Holdings, Inc (0000064463) (Issuer)

    6/12/25 7:14:22 PM ET
    $SLNH
    EDP Services
    Technology

    Director Patience John bought $314,000 worth of shares (200,000 units at $1.57) (SEC Form 4)

    4 - Accelerate Diagnostics, Inc (0000727207) (Issuer)

    12/3/24 8:48:49 PM ET
    $AXDX
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Michaels David C bought $31,577 worth of shares (9,100 units at $3.47), increasing direct ownership by 12% to 87,826 units (SEC Form 4)

    4 - Soluna Holdings, Inc (0000064463) (Issuer)

    6/20/24 8:06:10 PM ET
    $SLNH
    EDP Services
    Technology

    $AGTC
    $AXDX
    $IMRA
    $MOTS
    Leadership Updates

    Live Leadership Updates

    View All

    Soluna Appoints Michael Picchi as Chief Financial Officer

    Interim CFO David Michaels to remain on Soluna's Board following interim period Soluna Holdings, Inc. ("Soluna" or the "Company") (NASDAQ:SLNH), a developer of green data centers for intensive computing applications, including Bitcoin mining and AI, today announced it has appointed Michael Picchi as Chief Financial Officer and Treasurer, effective April 1, 2026. Picchi will lead Soluna's finance organization and support the Company's capital strategy as it scales its behind-the-meter, renewable-powered data center model and expands into Al. David Michaels, a member of Soluna's Board of Directors, has served as Interim Chief Financial Officer and Treasurer since August 2025. Michaels wil

    1/20/26 7:30:00 AM ET
    $SLNH
    EDP Services
    Technology

    Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Data from Positive VAX-24 Infant Phase 2 Dose-Finding Study

    Final Data from VAX-24 Infant Phase 2 Dose-Finding Study Consistent with Previously Reported Positive Interim Data; Provide Additional Evidence Supporting Higher VAX-31 Doses Being Evaluated in Ongoing Infant Phase 2 Study Modified VAX-31 Infant Phase 2 Dose-Finding Study Advanced to Third and Final Stage Company Expects to Initiate VAX-31 Adult Pivotal, Non-Inferiority Study in December 2025 with Topline Data in 2026 Company Establishing Fill-Finish Manufacturing in North Carolina as Key Element of Long-Term United States Commercial Supply Strategy, Aligned with Administration's Focus on Strengthening Domestic Biomanufacturing and Representing up to $1 Billion in Manufacturing and Servi

    11/4/25 4:05:00 PM ET
    $PCVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Soluna Appoints Agnes Budzyn to Board of Directors

    Former BlackRock and ConsenSys executive adds deep expertise in finance, digital assets, and technology Soluna Holdings, Inc. ("Soluna" or the "Company") (NASDAQ:SLNH), a developer of green data centers for intensive computing applications, today announced the appointment of Agnes Budzyn to its Board of Directors. Agnes brings more than a decade of experience across finance, digital assets, and technology strategy, with a proven track record of bridging traditional finance and emerging innovation. She currently serves as CEO and Managing Partner of Bluedge Ventures, an investment firm focused on digital infrastructure and dual-use technologies, and has previously held leadership roles a

    10/21/25 7:42:00 AM ET
    $SLNH
    EDP Services
    Technology

    $AGTC
    $AXDX
    $IMRA
    $MOTS
    Financials

    Live finance-specific insights

    View All

    Bitwise Announces Monthly Distributions for IMST, ICOI, IMRA, IGME, ICRC, and IETH

    SAN FRANCISCO, Jan. 22, 2026 /PRNewswire/ -- Bitwise Asset Management, a leading crypto asset manager, today announced the monthly distributions for its suite of Option Income Strategy ETFs: IMST, ICOI, IMRA, IGME, ICRC, and IETH.  Fund Ticker Distribution Per Share Distribution Rate 30-Day SEC Yield Return of Capital Ex-Date / Record Date Payment Date 1-Month Return 1-Year Return Since InceptionReturn Bitwise COIN Option Income Strategy ETF ICOI $0.50284 36.87 % 0.00 % 50.00 % 01/23/2026 01/27/2026 -4.93 % N/A -10.58 % Bitwise MARA Option Income Strategy ETF IMRA $0.20782 14

    1/22/26 4:21:00 PM ET
    $IMRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Bitwise Announces Monthly Distributions for IMST, ICOI, IMRA, IGME, ICRC, and IETH

    SAN FRANCISCO, Dec. 24, 2025 /PRNewswire/ -- Bitwise Asset Management, a leading crypto asset manager, today announced the monthly distributions for its suite of Option Income Strategy ETFs: IMST, ICOI, IMRA, IGME, ICRC, and IETH. Fund Ticker Distribution Per Share Distribution Rate 30-Day SEC Yield Return of Capital Ex-Date / Record Date Payment Date 1-Month Return 1-Year Return Since InceptionReturn Bitwise COIN Option Income Strategy ETF ICOI $2.24702 140.11 % 0.00 % 100.00 % 12/26/2025 12/30/2025 -2.82 % N/A -7.33 % Bitwise MARA Option Income Strategy ETF IMRA $1.41664 100.18 % 0.00 % 100.00 % 12/26/2025 12/30/2025 -9.45 % N/A -35.18 % Bitwise MSTR Option Income Strategy ETF IMST $1.30

    12/24/25 1:12:00 PM ET
    $IMRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Bitwise Announces Monthly Distributions for IMST, ICOI, IMRA, IGME, ICRC, and IETH

    SAN FRANCISCO, Nov. 26, 2025 /PRNewswire/ -- Bitwise Asset Management, a leading crypto asset manager, today announced the monthly distributions for its suite of Option Income Strategy ETFs: IMST, ICOI, IMRA, IGME, ICRC, and IETH. Fund Ticker Distribution Per Share Distribution Rate 30-Day SEC Yield Return of Capital Ex-Date / Record Date PaymentDate 1-Month Return 1-Year Return Since InceptionReturn Bitwise COIN Option Income Strategy ETF ICOI $2.59493 140.33 % 0.00 % 100.00 % 11/28/2025 12/2/2025 -27.20 % N/A -5.10 % Bitwise MARA Option Income Strategy ETF IMRA $1.69441 100.07 % 0.00 % 100.00 % 11/28/2025 12/2/2025 -40.17 % N/A -28.64 % Bitwise MSTR Option Income Strategy ETF IMST $1.503

    11/26/25 4:30:00 PM ET
    $IMRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGTC
    $AXDX
    $IMRA
    $MOTS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Accelerate Diagnostics Inc.

    SC 13D/A - Accelerate Diagnostics, Inc (0000727207) (Subject)

    12/5/24 5:13:13 PM ET
    $AXDX
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SC 13G/A filed by Vaxcyte Inc.

    SC 13G/A - Vaxcyte, Inc. (0001649094) (Subject)

    11/14/24 5:46:11 PM ET
    $PCVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Motus GI Holdings Inc.

    SC 13G/A - Motus GI Holdings, Inc. (0001686850) (Subject)

    11/14/24 4:22:34 PM ET
    $MOTS
    Medical/Dental Instruments
    Health Care